Chemed Corp. (CHE) Misses Q3 EPS by 7c; Guides FY12 EPS Below Consensus
Chemed Corp. (NYSE: CHE) reported Q3 EPS of $1.28, $0.07 worse than the analyst estimate of $1.35. Revenue for the quarter came in at $354 million versus the consensus estimate of $360.5 million.
Chemed Corp. sees FY2012 EPS of $5.20-5.30, versus the consensus of $5.37.
For earnings history and earnings-related data on Chemed Corp. (CHE) click here.
Chemed Corp. sees FY2012 EPS of $5.20-5.30, versus the consensus of $5.37.
For earnings history and earnings-related data on Chemed Corp. (CHE) click here.